BridgeMD
New treatment option for Infertility (IVF Patients)
Official title Ketorolac Use and Fresh Embryo Transfer Outcomes
ClinicalTrials.gov ID: NCT07185724
What this study is testing
What is Ketorolac 30 mg IV?
Ketorolac 30 mg IV is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for infertility (ivf patients).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Ketorolac is a medication often used to relieve pain after surgery. In the past, infertility doctors have been cautious about using ketorolac after egg retrieval for patients planning a fresh embryo transfer (usually done 5 days later).
- Phase 4: studies an already-approved treatment
- Time commitment: about 45 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 37, women only
You may be able to join if
- IVF utilizing autologous oocytes and all sperm sources
- IVF cycles utilizing ICSI and standard insemination
- Plan to transfer embryo on day 5
- BMI below 50
You likely can't join if
- -allergies or medical contraindications to NSAIDs
The study team makes the final eligibility decision.
Where it's taking place
- Iowa City, Iowa, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 45 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 18 years to 37 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Iowa City, Iowa, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.